These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29929107)

  • 1. In utero programming and early detection of cardiovascular disease in the offspring of mothers with obesity.
    Van De Maele K; Devlieger R; Gies I
    Atherosclerosis; 2018 Aug; 275():182-195. PubMed ID: 29929107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of parental over- and underweight on the health of offspring.
    Bellver J; Mariani G
    Fertil Steril; 2019 Jun; 111(6):1054-1064. PubMed ID: 31036339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic endocrinopathies (thyroid conditions and diabetes): impact on postnatal life of the offspring.
    Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF
    Fertil Steril; 2019 Jun; 111(6):1076-1091. PubMed ID: 31155115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Estrogen in Gender-dependent Fetal Programming of Adult Cardiovascular Dysfunction.
    Chen Z; Wang L; Ke J; Xiao D
    Curr Vasc Pharmacol; 2019; 17(2):147-152. PubMed ID: 29493455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk.
    Drake AJ; Reynolds RM
    Reproduction; 2010 Sep; 140(3):387-98. PubMed ID: 20562299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal obesity during pregnancy and cardiovascular development and disease in the offspring.
    Gaillard R
    Eur J Epidemiol; 2015 Nov; 30(11):1141-52. PubMed ID: 26377700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal/Infant Origins of Adult Vascular Disease.
    Paraskevas KI; Briana DD; Malamitsi-Puchner A; Mikhailidis DP
    Curr Vasc Pharmacol; 2020; 18(4):418-420. PubMed ID: 32129165
    [No Abstract]   [Full Text] [Related]  

  • 8. Excess nutrient supply in early life and its later metabolic consequences.
    Ojha S; Saroha V; Symonds ME; Budge H
    Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):817-23. PubMed ID: 23350968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenomics, gestational programming and risk of metabolic syndrome.
    Desai M; Jellyman JK; Ross MG
    Int J Obes (Lond); 2015 Apr; 39(4):633-41. PubMed ID: 25640766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life.
    Szostak-Węgierek D; Szamotulska K
    Med Wieku Rozwoj; 2011; 15(3):203-15. PubMed ID: 22006475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental vascular dysfunction, fetal and childhood growth, and cardiovascular development: the generation R study.
    Gaillard R; Steegers EA; Tiemeier H; Hofman A; Jaddoe VW
    Circulation; 2013 Nov; 128(20):2202-10. PubMed ID: 24135069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the developmental origins of cardiometabolic disease following exposure to maternal obesity and gestational diabetes
    Talbot CPJ; Dolinsky VW
    Appl Physiol Nutr Metab; 2019 Jul; 44(7):687-695. PubMed ID: 30500266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal obesity and the developmental programming of hypertension: a role for leptin.
    Taylor PD; Samuelsson AM; Poston L
    Acta Physiol (Oxf); 2014 Mar; 210(3):508-23. PubMed ID: 24433239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center.
    Silverman BL; Rizzo TA; Cho NH; Metzger BE
    Diabetes Care; 1998 Aug; 21 Suppl 2():B142-9. PubMed ID: 9704242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood.
    Tan HC; Roberts J; Catov J; Krishnamurthy R; Shypailo R; Bacha F
    Pediatr Diabetes; 2015 Sep; 16(6):419-26. PubMed ID: 25800542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of maternal obesity on fetal programming of cardiovascular disease.
    Roberts VH; Frias AE; Grove KL
    Physiology (Bethesda); 2015 May; 30(3):224-31. PubMed ID: 25933822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease.
    Rogers LK; Velten M
    Life Sci; 2011 Sep; 89(13-14):417-21. PubMed ID: 21821056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term consequences of obesity on female fertility and the health of the offspring.
    Chandrasekaran S; Neal-Perry G
    Curr Opin Obstet Gynecol; 2017 Jun; 29(3):180-187. PubMed ID: 28448277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease.
    Palinski W; Nicolaides E; Liguori A; Napoli C
    J Cardiovasc Transl Res; 2009 Sep; 2(3):277-85. PubMed ID: 19655024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of maternal overnutrition and gestational diabetes on the programming of metabolic health outcomes in the offspring: experimental evidence.
    Pereira TJ; Moyce BL; Kereliuk SM; Dolinsky VW
    Biochem Cell Biol; 2015 Oct; 93(5):438-51. PubMed ID: 25673017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.